Shandong Boan Biotechnology Co (HKSE:06955) Long-Term Capital Lease Obligation : HK$6.8 Mil (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Shandong Boan Biotechnology Co Long-Term Capital Lease Obligation?

Shandong Boan Biotechnology Co's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$6.8 Mil.

Shandong Boan Biotechnology Co's quarterly Long-Term Capital Lease Obligation increased from Dec. 2022 (HK$0.0 Mil) to Jun. 2023 (HK$8.8 Mil) but then declined from Jun. 2023 (HK$8.8 Mil) to Dec. 2023 (HK$6.8 Mil).

Shandong Boan Biotechnology Co's annual Long-Term Capital Lease Obligation declined from Dec. 2021 (HK$5.5 Mil) to Dec. 2022 (HK$0.0 Mil) but then increased from Dec. 2022 (HK$0.0 Mil) to Dec. 2023 (HK$6.8 Mil).

Shandong Boan Biotechnology Co Long-Term Capital Lease Obligation Historical Data

The historical data trend for Shandong Boan Biotechnology Co's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Boan Biotechnology Co Long-Term Capital Lease Obligation Chart

Shandong Boan Biotechnology Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

10.06

5.52

6.75

Shandong Boan Biotechnology Co Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial			5.52	1.55	-	8.79	6.75

Shandong Boan Biotechnology Co (HKSE:06955) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Shandong Boan Biotechnology Co Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Shandong Boan Biotechnology Co's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Shandong Boan Biotechnology Co (HKSE:06955) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shandong Boan Biotechnology Co Ltd (HKSE:06955) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

UJ9:Germany

Address

No. 39 Keji Avenue, High-Tech Industrial Development Zone, Shandong Province, Yantai, CHN

Website

https://www.boan-bio.com

Shandong Boan Biotechnology Co Ltd is a fully integrated biopharmaceutical company. The company is engaged in the development, manufacture, and commercialization of high-quality biologics in China and around the world. It focuses on areas such as oncology, metabolism, autoimmunity, and ophthalmology. Geographically company's revenue is generated from customers located in Mainland China.

Executives

Asiapharm Investments Ltd.
Ginkgo (ptc) Limited
Liu Dianbo
Luye Life Sciences Group Ltd
Luye Pharma Holdings Ltd.
Luye Pharma Hong Kong Limited
Luye Pharmaceutical International Co., Ltd.
Luye Pharmaceutical Investment Co., Ltd.
Nelumbo Investments Limited
Shorea Lbg
Luye Pharma Group Ltd.
Shan Dong Lv Ye Zhi Yao You Xian Gong Si
Yan Tai Lv Ye Yi Yao Kong Gu Ji Tuan You Xian Gong Si
Li Li	2201 Interest of corporation controlled by you

Shandong Boan Biotechnology Co (HKSE:06955) Headlines

No Headlines